Black Diamond Therapeutics, Inc.BDTXNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+67.1%
Studio
Year-over-Year Change

Year-over-year operating income growth rate

3Y CAGR
+67.1%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
4.7x
Strong expansion
Streak
2 yr
Consecutive growthAccelerating
PeriodValue
2025125.22%
20248.88%
20236.86%
202226.83%
2021-82.37%
2020-681.33%
20190.00%
2018-116.17%
20170.00%